V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200003999 | 200003999 | null | null | Palliative (P) | 2018-06-04 | 2018-06-15 | null | 02 | null | NIVOLUMAB | 101107977 |
| 200004005 | 200004005 | null | null | Palliative (P) | 2021-08-28 | 2021-08-29 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100508774 |
| 200004012 | 200004012 | null | null | Palliative (P) | 2017-06-27 | 2017-07-05 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101099328 |
| 200004013 | 200004013 | null | null | Palliative (P) | 2016-07-03 | 2016-07-07 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100826122 |
| 200004014 | 200004014 | null | null | Palliative (P) | 2018-09-30 | 2018-10-05 | NIVOLUMAB | 02 | null | IPILIMUMAB | 100394705 |
| 200004015 | 200004015 | null | null | null | null | 2017-08-30 | INTERIM Trial | null | null | ENCORAFENIB | 100879668 |
| 200004019 | 200004019 | null | null | null | null | 2017-11-15 | DABRAFENIB + TRAMETINIB | null | null | DABRAFENIB + TRAMETINIB | 100097477 |
| 200004020 | 200004020 | null | null | null | null | 2018-10-23 | Ipilimumab | null | null | BINIMETINIB + ENCORAFENIB | 101412829 |
| 200004021 | 200004021 | null | null | null | null | 2018-08-21 | CISPLATIN + GEMCITABINE | null | null | DABRAFENIB + TRAMETINIB | 100465501 |
| 200004024 | 200004024 | null | null | null | null | 2018-01-16 | DABRAFENIB | null | null | NIVOLUMAB | 100201870 |
| 200004041 | 200004041 | 1.5 | 0 | 03 | 2014-02-06 | 2014-03-14 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 100245763 |
| 200004050 | 200004050 | null | null | null | null | 2022-04-05 | NIVOLUMAB | null | null | HYDROXYCARBAMIDE | 100095671 |
| 200004059 | 200004059 | null | null | Palliative (P) | 2016-10-21 | 2016-11-04 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100790506 |
| 200004066 | 200004066 | 1.81 | 80.3 | Palliative (P) | 2016-09-02 | 2016-09-03 | null | 02 | null | ENZALUTAMIDE | 101563107 |
| 200004073 | 200004073 | null | null | Adjuvant (A) | 2017-07-09 | 2017-07-09 | Trial Unspecified | N | N | TRIAL | 100531073 |
| 200004074 | 200004074 | null | null | null | null | 2018-06-04 | NIVOLUMAB | null | null | NIVOLUMAB | 101480494 |
| 200004079 | 200004079 | null | null | 03 | 2016-11-29 | 2016-11-29 | null | 2 | null | PEMBROLIZUMAB | 101781663 |
| 200004096 | 200004096 | null | null | Palliative (P) | 2017-05-27 | 2017-06-07 | Trial Unspecified | 02 | N | BENDAMUSTINE + RITUXIMAB | 101548775 |
| 200004111 | 200004111 | null | null | Palliative (P) | 2013-12-09 | 2013-12-11 | null | N | N | PEMBROLIZUMAB | 100099555 |
| 200004115 | 200004115 | null | null | null | null | 2017-01-30 | DABRAFENIB + TRAMETINIB | null | null | TRIAL | 101643812 |
| 200004116 | 200004116 | null | null | Palliative (P) | 2018-08-06 | 2018-09-15 | NIVOLUMAB | N | null | TRIAL UNSPECIFIED | 101827043 |
| 200004120 | 200004120 | null | null | null | null | 2016-06-14 | NIVOLUMAB | null | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101074072 |
| 200004122 | 200004122 | null | null | null | null | 2013-02-10 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101844432 |
| 200004127 | 200004127 | null | null | Palliative (P) | 2019-07-16 | 2019-07-28 | Capecitabine | 02 | null | NIVOLUMAB | 100149688 |
| 200004131 | 200004131 | 1.68 | 74.5 | null | null | 2018-01-23 | BCG Intravesical | null | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101192008 |
| 200004135 | 200004135 | null | null | 03 | 2022-01-03 | 2022-01-03 | null | 02 | N | PEMBROLIZUMAB | 100078948 |
| 200004140 | 200004140 | null | null | null | null | 2020-04-25 | null | null | null | PEMBROLIZUMAB | 100907993 |
| 200004144 | 200004144 | null | null | null | null | 2020-01-10 | DABRAFENIB + TRAMETINIB | null | null | PEMBROLIZUMAB | 101471177 |
| 200004151 | 200004151 | null | null | null | null | 2019-04-14 | null | null | null | PEMBROLIZUMAB | 101473577 |
| 200004162 | 200004162 | null | null | null | null | 2019-02-17 | PEMBROLIZUMAB | null | null | IPILIMUMAB + NIVOLUMAB | 100054599 |
| 200004182 | 200004182 | null | null | Adjuvant (A) | 2017-11-12 | 2017-11-26 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101206214 |
| 200004194 | 200004194 | null | null | null | null | 2018-02-10 | DABRAFENIB + TRAMETINIB | null | null | DABRAFENIB + TRAMETINIB | 100706198 |
| 200004197 | 200004197 | null | null | Palliative (P) | 2017-02-28 | 2017-02-28 | null | 2 | null | IXAZOMIB + LENALIDOMIDE | 101655636 |
| 200004220 | 200004220 | null | null | Curative (C) | 2021-06-16 | 2021-06-16 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101202538 |
| 200004222 | 200004222 | null | null | Palliative (P) | null | 2017-09-29 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 100633178 |
| 200004257 | 200004257 | null | null | Palliative (P) | 2020-06-15 | 2020-06-15 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100786637 |
| 200004264 | 200004264 | null | null | Palliative (P) | 2019-02-22 | 2019-02-24 | Dacarbazine | 02 | null | TRIAL UNSPECIFIED | 101776499 |
| 200004267 | 200004267 | null | null | Palliative (P) | 2018-09-23 | 2018-09-23 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100555985 |
| 200004271 | 200004271 | null | null | Palliative (P) | 2017-11-22 | 2017-12-08 | PEMBROLIZUMAB | N | null | PEMBROLIZUMAB | 101523680 |
| 200004276 | 200004276 | null | null | Palliative (P) | 2016-11-17 | 2016-11-17 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101854236 |
| 200004282 | 200004282 | null | null | null | null | 2018-08-31 | CAPECITABINE + OXALIPLATIN | null | null | TRIAL UNSPECIFIED | 100679796 |
| 200004291 | 200004291 | null | null | Curative (C) | 2017-09-11 | 2017-09-11 | NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101397857 |
| 200004297 | 200004297 | 1.75 | 88 | Palliative (P) | 2017-05-01 | 2017-05-01 | null | 02 | null | PEMBROLIZUMAB | 100391254 |
| 200004298 | 200004298 | null | null | Neo-adjuvant (N) | 2014-09-11 | 2014-09-11 | null | N | N | NIVOLUMAB | 101096847 |
| 200004305 | 200004305 | null | null | Neo-adjuvant (N) | 2019-06-17 | 2019-06-18 | null | 2 | null | DABRAFENIB + TRAMETINIB | 101768850 |
| 200004326 | 200004326 | 1.51 | null | Palliative (P) | 2019-02-03 | 2019-02-05 | PEMBROLIZUMAB | 02 | null | DABRAFENIB + TRAMETINIB | 100369566 |
| 200004328 | 200004328 | null | null | null | null | 2017-10-25 | null | null | null | PEMBROLIZUMAB | 100366324 |
| 200004335 | 200004335 | null | null | null | null | null | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100368248 |
| 200004339 | 200004339 | null | null | null | null | 2016-02-26 | null | null | null | DABRAFENIB + TRAMETINIB | 100029223 |
| 200004366 | 200004366 | null | null | 03 | 2018-03-27 | 2018-03-27 | null | 01 | null | IPILIMUMAB + NIVOLUMAB | 101747701 |